Can deep brain stimulation for psychiatric disorders produce durable improvements in real-world settings?

Does DBS for depression hold up over years in the real world?

Yes, for a subset of patients, the benefits of DBS for treatment-resistant depression can last for years and translate into real improvements in daily life. A 2022 study followed 25 patients with major depression who received DBS of the ventral anterior limb of the internal capsule (vALIC) for an average of 7.7 years [1]. The response rate—defined as a 50% or greater drop in depression scores—remained stable at around 40% from year 3 through year 6, and was 44% at the last follow-up. Importantly, quality of life across physical, psychological, and environmental domains also improved and stayed elevated over the long term, meaning the treatment wasn't just reducing symptoms on paper but actually helping people function better in their real lives. The study also included a randomized crossover phase where patients did better on active stimulation than sham, confirming the effect was due to the DBS itself, not just the passage of time.

Can newer 'responsive' DBS systems improve real-world outcomes for Tourette syndrome?

A newer approach called responsive DBS—which delivers stimulation only when it detects brain signals linked to tics—shows promise for Tourette syndrome in real-world settings, though it's still experimental. In a 2024 NIH-funded study of 10 patients, 8 received chronic responsive DBS targeting the centromedian thalamus, and 4 out of those 8 (50%) met the primary outcome of a 30% or greater reduction in motor tic severity at 6 months [2]. The system was safe and well-tolerated, and the researchers demonstrated that it could be triggered by brain activity alone, without needing a patient or caregiver to activate it. This is a real-world advantage because tics are unpredictable and can be embarrassing or disruptive; a device that responds automatically could improve quality of life more than constant, open-loop stimulation. However, half the patients did not meet the threshold, so it's not a universal solution.

What are the limitations—where does DBS fall short in real-world settings?

Despite these encouraging results, DBS for psychiatric disorders is not a guaranteed fix, and the evidence has important gaps. First, the depression study [1] was naturalistic (not a controlled trial for the long-term phase), and only 25 patients were included—a small sample. The Tourette study [2] was also small (10 patients) and only followed for 6 months, so long-term durability is unknown. Second, a 2022 systematic review of closed-loop DBS (a related technology) found only 7 studies total, and just one focused on a psychiatric disorder (major depression, with a single patient) [3]. The review concluded there is insufficient evidence that closed-loop DBS offers superior clinical outcomes over standard open-loop DBS. Third, a 2026 review of PET imaging in DBS for psychiatric disorders noted that while brain scans show changes that correlate with symptom improvement, the clinical significance of those changes remains unclear [4]. Finally, a 2022 study on childhood mental health services—not DBS specifically—found that treating psychiatric problems early did not necessarily prevent adult disorders, suggesting that even effective interventions may not alter long-term trajectories for everyone [5]. This underscores that DBS, like all psychiatric treatments, may need to be part of a broader, ongoing care plan.

About These Sources

This answer is built on 5 peer-reviewed studies — published from 2022 to 2026, 2 from 2024 or later, 2 in Q1 journals, collectively cited 66 times — selected as the most relevant from 5 studies that passed quality screening, drawn from 51 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions